ADMA — ADMA BIOLOGICS INC

Ownership history in Virtu Financial LLC  ·  9 quarters on record

This page tracks every 13F SEC filing in which Virtu Financial LLC reported a position in ADMA BIOLOGICS INC (ADMA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.04% (2020 Q3)
Avg. % of fund
0.01%
First filed
2017 Q4
Last filed
2025 Q3
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 19,200 +1,990 +11.6% 0.02% $281K $14.66
2025 Q2 REDUCED 17,210 -1,782 -9.4% 0.02% $313K $18.21
2024 Q4 REDUCED 18,992 -5,692 -23.1% 0.02% $326K $17.15
2023 Q2 REDUCED 24,684 -11,439 -31.7% 0.01% $91K $3.69
2022 Q3 ADDED 36,123 +18,935 +110.2% 0.01% $88K $2.43
2022 Q2 REDUCED 17,188 -71,127 -80.5% 0.00% $34K $1.98
2021 Q4 REDUCED 88,315 -5,390 -5.8% 0.01% $125K $1.41
2020 Q3 ADDED 93,705 +70,517 +304.1% 0.04% $224K $2.39
2017 Q4 INITIATED 23,188 — — 0.00% $74K —
% of Fund (quarterly)    ADMA price (monthly, adj. close)

Other funds also holding ADMA

As of 2025 Q4 — sorted by position size

B Group, Inc. 33.1% Stonepine Capital Management, LLC 3Y 7Y 9.85% Sachem Head Capital Management LP 3Y 7Y 4.86% Caligan Partners LP 3Y 4.52% AWM Investment Company, Inc. 3Y 7Y 3.87% Ranger Investment Management, L.P. 3Y 7Y 2.88% PFM Health Sciences, LP 3Y 7Y 2.31% MARATHON CAPITAL MANAGEMENT 3Y 7Y 1.83% Catalio Capital Management, LP 1.82% FINDELL CAPITAL MANAGEMENT LLC 1.57%
← Back to Virtu Financial LLC Holdings